Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “breast cancer”

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsRecruiting
NCT05232916Phase 3Updated Aug 6, 2026
Sponsor: Greenwich LifeSciences, Inc.
Breast Cancer
United States, Belgium, France, Germany, Ireland +5 more
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationRecruiting
NCT05877599Phase 1Updated Aug 6, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Colorectal Carcinoma · Pancreatic Adenocarcinoma
United States
Generative AI Patient Education Module for Breast OncologyRecruiting
NCT07512271NAUpdated Aug 6, 2026
Sponsor: University of California, San Francisco
Breast Cancer · Metastatic Breast Cancer · Carcinoma of the Breast
United States
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerRecruiting
NCT05386108Phase 1, Phase 2Updated Aug 6, 2026
Sponsor: Stemline Therapeutics, Inc.
Breast Neoplasms · Brain Neoplasms · Neoplasms by Site · Neoplasms
United States, Belgium, France, Germany, Greece +5 more
A Study to Investigate Mechanisms of Resistance to Breast Cancer TherapiesRecruiting
NCT06274515Phase 4Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Breast Cancer
Belgium, Denmark, Finland, Germany, Italy +3 more
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadRecruiting
NCT06324357Phase 1, Phase 2Updated Aug 6, 2026
Sponsor: Boehringer Ingelheim
Metastatic Breast Cancer · Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma
United States, Belgium, China, France, Germany +5 more
DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEsRecruiting
NCT06176261Phase 2Updated Aug 6, 2026
Sponsor: Nancy Lin, MD
Breast Cancer · Breast Cancer Female · Metastatic Triple-Negative Breast Carcinoma · ER Positive Breast Cancer
United States
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerRecruiting
NCT07368998Phase 2Updated Aug 6, 2026
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Belgium, Mexico +3 more
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast CancerRecruiting
NCT06439693Phase 2Updated Aug 6, 2026
Sponsor: Dana-Farber Cancer Institute
Breast Cancer Female · Breast Cancer · Breast Cancer Metastatic · Estrogen Receptor-positive Breast Cancer
United States
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerActive Not Recruiting
NCT02311933Phase 2Updated Aug 6, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent Breast Carcinoma · Stage III Breast Cancer AJCC v7 · Stage IIIA Breast Cancer AJCC v7 · Stage IIIB Breast Cancer AJCC v7
United States
Negative/Low Hormone Receptor and APOcrine Lobular Invasive Breast Carcinoma - A Real-World International Cohort StudyRecruiting
NCT07613151N/AUpdated Aug 6, 2026
Sponsor: Istituto Oncologico Veneto IRCCS
Lobular Breast Carcinoma
Italy
The Effect of Artificial Intelligence Chatbot and Expert Education on Breast Cancer Awareness Among Female Municipal EmployeesCompleted
NCT07749677NAUpdated Aug 6, 2026
Sponsor: Eskisehir Osmangazi University
Breast Cancer Awareness
Turkey (Türkiye)
STOP-HER2: Stopping Trastuzumab in HER2+ MBCActive Not Recruiting
NCT05721248Phase 2Updated Aug 6, 2026
Sponsor: Dana-Farber Cancer Institute
Breast Cancer · Metastatic Breast Cancer · HER2-positive Breast Cancer
United States
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruiting
NCT07749586Phase 1, Phase 2Updated Aug 6, 2026
Sponsor: Arvinas Inc.
Advanced Solid Tumor
United States
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast CancerCompleted
NCT01547741Phase 3Updated Aug 6, 2026
Sponsor: NSABP Foundation Inc
Breast Cancer
United States, Puerto Rico
SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical TrialActive Not Recruiting
NCT05814354Phase 3Updated Aug 6, 2026
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Breast Cancer
China
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast CancerRecruiting
NCT05507879N/AUpdated Aug 5, 2026
Sponsor: Mayo Clinic
Breast Carcinoma · Cardiomyopathy · Congestive Heart Failure
United States
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerRecruiting
NCT06790693Phase 3Updated Aug 5, 2026
Sponsor: Hoffmann-La Roche
Breast Cancer
United States, Argentina, Australia, Brazil, Canada +15 more
HER2+ CNS SurveillanceRecruiting
NCT07748598NAUpdated Aug 5, 2026
Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust
Her 2 Positive Breast Cancer · Cancer · CNS
United Kingdom
Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruiting
NCT07059884NAUpdated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Localized Malignant Solid Neoplasm · Anal Cancer · Bladder (Urothelial, Transitional Cell) Cancer · Breast Cancer
United States
De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early BreastNot Yet Recruiting
NCT07748260Phase 3Updated Aug 5, 2026
Sponsor: Guangdong Provincial People's Hospital
HER2-positive Breast Cancer
Promoting Breast Cancer Screening in Women Who Survived Childhood CancerActive Not Recruiting
NCT01579552Phase 3Updated Aug 5, 2026
Sponsor: Memorial Sloan Kettering Cancer Center
Cancer
United States
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Recruiting
NCT06330064Phase 1, Phase 2Updated Aug 5, 2026
Sponsor: Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
United States, Argentina, Australia, Belgium, Brazil +13 more
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting
NCT05334069N/AUpdated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Ann Arbor Stage I Lymphoma · Ann Arbor Stage II Lymphoma
United States
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerRecruiting
NCT06982521Phase 3Updated Aug 5, 2026
Sponsor: Relay Therapeutics, Inc.
PIK3CA Mutation · HER2- Negative Breast Cancer · Hormone Receptor Positive Tumor · Breast Cancer
United States, Argentina, Australia, Austria, Belgium +19 more

Previous page Next page